Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Unicycive Therapeutics (UNCY) Long-Term Debt Issuances (2020 - 2021)

Unicycive Therapeutics posted quarterly Long-Term Debt Issuances of $88000.0 for Q2 2021, down 91.29% on a QoQ basis from $1.0 million in Q1 2021.

Unicycive Therapeutics (UNCY) has 2 years of Long-Term Debt Issuances data on file, last reported at $88000.0 in Q2 2021.

  • For the quarter ending Q2 2021, Long-Term Debt Issuances changed N/A year-over-year to $88000.0; the trailing twelve-month figure through Dec 2021 stood at $1.1 million (changed N/A YoY), and the FY2021 full-year result was $1.1 million, down 14.88% from the prior year.
  • Long-Term Debt Issuances for Q2 2021 stood at $88000.0, down from $1.0 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $1.0 million in Q1 2021 and bottomed at $88000.0 in Q2 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 2.73 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Unicycive Therapeutics 181.94 Mn 127.36 Mn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2021 88,000.00
Jun 30, 2021 88,000.00
Mar 31, 2021 1.01 Mn
Mar 31, 2021 1.01 Mn
Dec 31, 2020 390,000.00
Dec 31, 2020 390,000.00